Edit |   |
---|---|
Antigenic Specificity | CD3E, Human (Otelixizumab biosimilar) |
Clone | Otelixizumab |
Host Species | Recombinant Rat |
Reactive Species | human |
Isotype | IgG1 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM, IP, ELISA, Neut, FuncS, IF, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD3E Recombinant Antibody (Otelixizumab). Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories. |
Immunogen | n/a |
Other Names | Anti-CD3E Recombinant Antibody, Research Grade Otelixizumab, Anti-Human CD3E Recombinant Antibody(Otelixizumab), ChAglyCD, TRX4, otelixizumab, 881191-44-2, TRX4, Antibody Drug Analogues, Monoclonal Antibody, YR1152, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 881191-44-2 |
Catalog # | YR1152 |
Price | please inquire |
Order / More Info | CD3E, Human (Otelixizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |